Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

78.00
EUR
-4.00
(-4.88%)
-3.46EPS
4.48BMarket Cap
Mar 16Next Earn

Dianthus Therapeutics, Inc. Documents

Q1 FY2024 · Quarterly report

May 9, 2024 · 52 pages

Read Dianthus Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q1 FY2024 documents